Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

52 results about "Schizandrin B" patented technology

Chinese magnoliavine fruit monomer composition separation preparation method

The invention relates to a Chinese magnoliavine fruit monomer composition separation preparation method; ethanol extracts from Chinese magnoliavine fruit are extracted by petroleum ether, chromatography is carried out to the petroleum ether extracts by a silicagel column, and then the petroleum ether is eluted by petroleum ether-ethylacetate, and HPLC is used for monitoring, and then crude extract A and crude extract B are fraction-collected, and eluted; the volume ratio of eluant petroleum ether and ethylacetate is 3-5:1, the crude extract A and crude extract B are respectively applied to a high-speed counter-current chromatography for separation, so as to obtain SCHisanhenol, deoxyschizandrin, schizandrin B, schisandrin C, schizandrol A, schizandrol B and schisantherrin B monomers, and the purity is higher than 98 percent.
Owner:华美恒盛(北京)科技有限公司

Method for controlling the quality of schisandra raw material fingerprint in the plant medicine for improving hemorheology

The invention relates to a schisandra fruit fingerprint spectrum quality control method, comprising that (1), adding 0.5g schisandra fruit to extract via microwave for 50min, filtering, (2), washing flow phase gradient that the spectrum column is Eclipse, as 0-40min, 60-20% A, 40-80% B, flow speed is 0.8-1.2ml / min, the wavelength is 210-280nm, the column temperature is 20-40Deg. C, and the sample amount is 10-20ul, (3), building standard fingerprint spectrum that the first peak is schisandra fruit alcohol 1, the third peak is schisandra fruit alcohol 2, the fourth peak is gemixin N / isomer, the sixth peak is schisandra fruit I element, the seventh and eighth peaks are gemixin N / isomer, the ninth peak is schisandra fruit II element, (4), controlling the quality of fingerprint spectrum that the check peak relative holding times are 1.00, 1.25, 1.63, 1.88, 3.18 and 3.27, (5), the schisandra fruit planting collecting method. The invention can control the quality of materials to assure the stable quality of product.
Owner:SHANGHAI MODERN CHINESE TRADITIONAL MEDICINE TECH DEV

Traditional Chinese medicine composition for treating male infertility, preparation method and quality control method thereof

The invention relates to a traditional Chinese medicine composition used for treating male sterility, a preparation method and a quality control method thereof. The traditional medicine composition contains crude drugs such as fruits of Chinese wolfberry, dodder (fried), raspberry, fructus schizandrae (steamed), plantago seeds (fried with salt) and the like. The preparation method comprises an ultrafine grinding technology and the like. The quality control method of the medicine composition comprises a thin-layer identification method for fruits of Chinese wolfberry, dodder, raspberry, fructus schizandrae and plantago seeds as well as a method for measuring the content of schizandrin B in the plantago seeds. The medicine composition has obvious therapeutic effect in treating renal deficiency and lumbago, post-micturition dribble, spermatorrhea, premature ejaculation, impotence and sterility.
Owner:BEIJING ASIA EAST BIO PHARMA CO LTD

Use of schisandrin B in anti-liver fibrosis

The invention belongs to the field of traditional Chinese medicines or the pharmaceutical chemistry, and relates to a use of schisandrin B or a Chinese magnoliavine extract in the preparation of medicines for treating and / or adjunctively treating and / or preventing liver fibrosis or liver cirrhosis, medicines for treating or adjunctively treating diseases caused by the liver fibrosis or liver cirrhosis, or medicines for inhibiting liver stellate cell proliferation or DNA synthesis. The invention also relates to a method for inhibiting the liver stellate cell proliferation or inhibiting the liver stellate cell DNA synthesis in vitro / in vivo, and a medicinal composition containing the schisandrin B or the Chinese magnoliavine extract. It is proved that the schisandrin B can obviously improve the liver fibrosis or the liver cirrhosis degree, has no obvious hepatotoxicity and has a good application prospect.
Owner:INST OF PHARMACOLOGY & TOXICOLOGY ACAD OF MILITARY MEDICAL SCI P L A

Detection of blood plasma schizadrin b of dissipating blood stasis botanical

A detection method of blood plasma schizadrin B of dissipating blood stasis botanical is disclosed. The method includes: (1) extracting schizadrin B from plasma of mammalian administered dissipating blood stasis botanical by ethyl acetate with the volume ratio 1:4, whirling 3-5 mins, centrifugating at 9600 rpm for 10 mins, drying and enriching the upper layer at 25-30° C., and redissolving with mobile phase; (2) UPLC / MS measuring: UPLC condition: chromatographic column: Acquity UPLC BEH C18, 2.1′100 mm, mobile phase A: water-acetonitrile-formic acid 95:5:0.1 v / v / v, mobile phase B: acetonitrile-formic acid 100:0.1 v / v; MS condition: electric spraying ion source(ESI), detecting with positive ion mode, scanning at the range of m / z 150-1200. The method can be used for pharmacokinetics study of schizadrin B in dissipating blood stasis botanical.
Owner:SHANGHAI MODERN CHINESE TRADITIONAL MEDICINE TECH DEV

Method for processing vinegar schisandra fruit

The invention relates to a method for processing vinegar schisandra fruit, which can effectively prepare medicinal material of the schisandra fruit into vinegar schisandra fruit medical herb in pieces. The invention has the concrete technical scheme comprises the following steps: taking the medicinal material of the schisandra fruit, removing the non-medicinal parts such as fruit stalks, stumps and the like, adding rice vinegar, decompressing and moistening until the rice vinegar is sucked up, braising at high pressure, drying and packaging so as to obtain the vinegar schisandra fruit. The method is simple and easy to operate, the color of the prepared vinegar schisandra fruit is uniform, and the indexes of the contents of water content, ash content and the like are all within a range specified by a dispensatory; compared with a normal-pressure vinegar braising product of the vinegar schisandra fruit, no obvious difference exists in the contents of general lignanoid, schisandrol A, schisandra fruit essence B and general organic acid; compared with the normal-pressure vinegar braising product, the contents of 5-hydroxymethyl furfural and general polysaccharide are higher; and compared with a traditional normal-pressure braising process, the processing method adopting high-pressure vinegar braising lowers energy consumption and saves time. Therefore, the invention can be popularized and used for large-scale production, provides concrete technical data for the processing of the vinegar schisandra fruit and provides ground for the execution of the standardized production operation rule of traditional Chinese medicine medical herb in pieces.
Owner:BEIJING HUAMIAO TRADITIONAL CHINESE MEDICINE ENG TECH DEV CENT

Method for measuring content of Shenqi blood sugar reducing preparation and application thereof in overall quality control

The invention provides a method for measuring the content of a Shenqi blood sugar reducing preparation. The method is used for measuring the content of 10 active ingredients in the Shenqi blood sugar reducing preparation: ginsenoside Rb1, ginsenoside Rc, ginsenoside Rd, ginsenoside Rg1, ginsenoside Re, astragaloside, deoxyschizandrin, schisandrol A, schisandrol B. In the invention, with the guidance of blood sugar reducing activity of a compound, multiple active substances in the compound are detected, and the quality level of the whole compound preparation can be reflected better; meanwhile, a Q-MS ion monitoring mode is selected for content measurement, and the mass spectrum quantification has high accuracy, specificity and sensitivity and is superior to traditional HPLC analysis method; and moreover, fingerprint is established according to the liquid phase diagrams of different batches of Shenqi blood sugar reducing preparations obtained by the method, the similarity is evaluated, the inherent quality of the Shenqi blood sugar reducing preparation product is evaluated more scientifically and comprehensively, and a basis is provided for establishing a quality standard of higher level.
Owner:ZHEJIANG UNIV OF TECH

Preparation method of liver protection tablets

The invention provides a preparation method of liver protection tablets. The liver protection tablets are prepared from the raw material medicines of 250g of radix bupleuri, 250g of herba artemisiae scopariae, 250g of radix isatidis, 300g of fructus schisandrae chinensis, 20g of pig bile powder and 128g of mung bean by microwave extraction. Through the invention, the content of schisandrin b is greatly increased.
Owner:NANJING ZHENGLIANG MEDICAL TECH

Process for preparing high-purity deoxyschizandrin

This invention relates to a method of preparing high-purity Schisandrin B. The invention adopts analysis mode high speed counter-current chromatography to proceed small scale preparation, adopt semipreparative type high speed counter-current chromatography to proceed large-scale preparation. The feature is that in solvent system the volume ratio of normal hexane, methanol, water and acetonitrile is 5 - 11 : 3 - 6 : 2 - 5 : 1, and the best volume ratio is 10:5:4:3. The invention does not need solid padding, has no irreversible adsorption and no pollution.The purity of gained Schisandrin B can reach 98%upwards.
Owner:赵景辉

Radiosensitizer compositions comprising schisandra chinensis(turcz.)baill and methods for use

The present invention provides a method of potentiating radiation therapy for treatment of a cancer or tumor comprising administrating to a subject in need thereof a therapeutically effective amount of a radiosensitizer in combination of a radiation therapy to a locus of the cancer or tumor, wherein the radiosensitizer is an extract of Schisandra chinensis (Turcz.) Baill, or the active ingredient isolated therefrom, particularly Schisandrin B.
Owner:ETEN BIOTECH

Chinese magnoliavine fruit lignan single component preparation

The invention discloses a Chinese magnoliavine fruit lignan single component preparation, and belongs to the technical field of medicines, and especially, by addition of a surfactant into a lipophilic Chinese magnoliavine fruit lignan extract for formation of a uniform aqueous solution, macroporous adsorption resin can be effectively used for preliminary purification, subsequent chromatographic purification operation load can be reduced, then ODS-A-HG or ODS-A reversed-phase C18 packing is used for chromatographic purification, and an ethanol aqueous solution is used for gradient elution to obtain schizandrin a, schizandrin b, schisantherin a, schisantherin b, deoxyschizandrin, and schisandrin b single components with the purity of more than 98%. The method has the advantages of being simple in operation, non-pollution, low in cost, less in time consuming, high in yield, easy to enlarge in industry, and the like.
Owner:YANTAI UNIV

Medical composite for preventing and curing Alzheimer's disease

The invention discloses a medical composite for preventing and curing Alzheimer's disease (AD). The composite comprises the following raw materials in parts by weight: 10-40 parts of hyperin, 20-80 parts of icariin and 5-20 parts of Schisandrin B. Experiments of rat place navigation and space exploration prove that the medical composite of the invention can increase the ability of spatial learning and memory of AD rat model, namely reduce the escape latency and scouting distance and obviously increase the percent of scouting time in quadrant of original platform to total time and the percent of scouting distance in quadrant of original platform to total distance in space exploration experiments. Therefore, the extract composite can be used for preventing and curing AD.
Owner:PEKING UNIV FIRST HOSPITAL

Medicinal composition for treating diabetes hepatic fibrosis

The invention belongs to the field of traditional Chinese medicines or the pharmaceutical chemistry, and relates to a medicinal composition for resisting hepatic fibrosis and / or hepatic cirrhosis. The medicinal composition includes ursolic acid and schisandrin B. The invention also relates to a use of the medicinal composition in the preparation of medicines for treating and / or preventing and / or adjunctively treating hepatic fibrosis and hepatic cirrhosis, or medicines for inhibiting hepatic stellate cell proliferation or inhibiting hepatic stellate cell DNA synthesis, and a method for inhibiting hepatic stellate cell proliferation or inhibiting hepatic stellate cell DNA synthesis. The medicinal composition can obviously improve the hepatic fibrosis degree, has the advantages of few components, strong effect, simple preparation, no obvious hepatotoxicity, and good market prospect, and is of certain practical significance for promoting traditional Chinese medicinal modernization.
Owner:INST OF PHARMACOLOGY & TOXICOLOGY ACAD OF MILITARY MEDICAL SCI P L A

Application of schisandrin b in preparing NADPH oxidase inhibitor

InactiveCN104147001AModerate inhibitory activityGood biological low toxicityNervous disorderRespiratory disorderLymphatic SpreadOxygen ions
The invention provides an application of schisandrin b in preparing an NADPH oxidase inhibitor. The NADPH oxidase comprises various sub-types of oxidase. In in-vitro enzymatic experiments, the schisandrin b is capable of inhibiting super-oxygen ion generation reaction catalyzed by NADPH oxidase and reactive oxygen generation related to NADPH oxidase in cells, and does not have the function of scavenging free radicals, thus being an inhibitor of the NADPH oxidase. Furthermore, the NADPH oxidase is capable of changing the level of a plurality of signal transduction pathways and inhibiting generation of tumor metastasis, and can be applied to preparation of medicaments for treating tumor metastasis.
Owner:ZHEJIANG UNIV

Application of biphenyl cyclo-octadiene lignans for reducing toxic and side effect of antitumor agent

The invention discloses a preparing method of biphenyl cyclo-octadiene lignans and application in the tumour prevention drug, which is characterized by the following: reducing cardiovascular toxicant or liver toxicant or kidney toxicant or marrow inhibition or immune inhibition or alopecia, adopting schizandrin to lessen side-effect of tumour prevention drug effectively.
Owner:梦阳药业上海有限公司

Application of monomeric compounds of fruits of Chinese magnoliavine (Schisandra chinensis(Turcz.) baill. and Schisandra sphenanthera Rehd.et Wils) to preparation of medicine for preventing and treating cholestasis liver diseases

InactiveCN107569481APrevention and Treatment of Congestive Liver InjuryProve the effect of the treatmentDigestive systemEther/acetal active ingredientsAlanine aminotransferaseHepatica
The invention discloses application of monomeric compounds of fruits of Chinese magnoliavine (Schisandra chinensis(Turcz.) baill. and Schisandra sphenanthera Rehd.et Wils) to preparation of medicine for preventing and treating cholestasis liver diseases. The monomeric compounds of fruits of Chinese magnoliavine refer to Schisandrin B, Schisandrin C, Schisandrol A, Schisantherrin A and Schisantherrin B. The result of the study shows that all of the five kinds of monomeric compounds can obviously reduce the content of total bile acids and direct bilirubin in blood serum in the cholestasis liverdisease state, can relieve the cholestasis symptoms, can reduce the activity of alkaline phosphatase, gamma-glutamyltransferase, aspartate transaminase and / or alanine aminotransferase in the liver, and can effectively improve the liver tissue necrosis degree. The invention discovers the condition for the first time that the five kinds of monomeric compounds of fruits of Chinese magnoliavine can beused for effectively preventing and treating the cholestasis liver diseases induced by liithocholic acid. The discovery provides the powerful technical theoretical basis for the new medicine researchand development for the cholestasis liver diseases and the clinic application of the monomeric compounds of fruits of Chinese magnoliavine; and wide application prospects are realized in the field ofcholestasis prevention and treatment.
Owner:SUN YAT SEN UNIV

Compound plant growth regulator containing brassinolide compound

The invention discloses a compound plant growth regulator containing a brassinolide compound, and relates to the technical field of plant growth regulators. The compound plant growth regulator disclosed by the invention comprises active components and a synergist, wherein the active components comprises a brassinolide compound and one or two selected from (+)-abscisic acid and indolebutyric acid,and the synergist comprises schisandrin B, alisol B acetate and an alcohol solution of alkannin. The compound plant growth regulator not only has an obvious synergistic effect, but also can improve the germination rate, promote growth of plant roots and crowns, further improve quality of crops and improve the yield of the crops. The schisandrin B, the alisol B acetate and the alkannin are preparedinto the synergist to be matched with the active components for use, so that nutrient substances required by plants are provided, quality of crops is improved, growth of the crops is promoted, and the effect of increasing production and income is achieved.
Owner:江西鑫邦科技有限责任公司

Application of schisandrin B in preparation of diabetes treatment drug

The invention discloses an application of schisandrin B in preparation of a diabetes treatment drug and provides pharmaceutical composition taking the schisandrin B as the effective component. The pharmaceutical composition can effectively reduce the blood glucose level of a diabetic patient, and the effective action concentration is far lower than metformin which is a first-line drug in the market.
Owner:ZHEJIANG UNIV

Endophytic fungi for improving content of main active ingredients of schisandra chinensis through fermentation method

The invention relates to an endophytic fungi for improving content of main active ingredients of schisandra chinensis through a fermentation method. The endophytic fungi is Aspergilluspenicillioides WT4 which is preserved in the China Center for Type Culture Collection (CCTCC) with preservation numbers of CCTCC No: M2012043 in Wuhan University in Wuhan city, and the preservation date is February 29, 2012. The WT4 in the endophytic fungi can remarkably improve the main active ingredients of the schisandra chinensis, such as schizandrin, schisantherin, deoxyschizandrin and schisandrin b. Therefore, in the raw material production with the purpose of obtaining the schizandrin, the schisantherin, the deoxyschizandrin and the schisandrin b, people can select schisandra chinensis endophytic fungi WT4 to ferment the schisandra chinensis to improve the yield and save medicinal resources.
Owner:HEILONGJIANG UNIV

Three Chinese magnoliavine fruit extracts as well as preparation process and application thereof

The invention discloses three Chinese magnoliavine fruit extracts as well as a preparation process and application thereof, and belongs to the technical field of medicines. The preparation method of the Chinese magnoliavine fruit extract comprises the following steps: treating Chinese magnoliavine fruit by using a CSFE method to obtain an extract A, and placing the extract at room temperature for layering to obtain an extract B (rich in schisandrin B) and an extract C (rich in schizandrin); boiling the decoction dregs, adding beta-cyclodextrin into filtrate to carry out inclusion adsorption on residual fat-soluble active ingredients in the decoction dregs, and filtering to obtain the inclusion adsorption lignan; performing concentration and alcohol precipitation on the filtrate to obtain the Chinese magnoliavine fruit polysaccharide; respectively combining the inclusion adsorption lignan and polysaccharide with the extracts A, B and C to obtain an extract I, an extract II and an extract III. The content of effective parts of the three extracts accounts for more than 50% of the extracts, the three extracts are composed of three active components including total lignan, linoleic acid and polysaccharide, and the total lignan is 18-25%. Different new drugs can be developed from the three extracts according to different proportions of schisandrin B and schizandrin for resisting depression, promoting sleep, promoting intelligence and other indications.
Owner:沈嘉

Novel natural herbal compound composition with sobering and liver protection effects and application thereof

The invention discloses a novel natural herbal compound composition with sobering and liver protecting effects and preparation as well as application thereof. The composition is prepared from active ingredients which mainly have the sobering and liver protecting effects and auxiliary materials, wherein the composition of the active ingredients comprise the following components in percentage by weight based on total weight of the active ingredients: 3-10 percent of sesamin, 0.05-5 percent of schisandrin, 10-45 percent of hovenia dulcis thumb extract, 10-45 percent of kudzu vine flower extract, 10-45 percent of nutgrass galingale rhizome extract, 0-0.02 percent of vitamin B12 and 1-10 percent of vitamin E acetate. The invention also relates to application of the composition to preparation of health care foods for preventing and / or treating acute alcoholism, health care foods for treating chronic alcoholic liver damage and health care foods for treating nonalcoholic fatty liver. The composition has the advantages of good synergistic reaction among the components, obvious curative effect, readily available raw materials, easiness in preparation and relatively low cost.
Owner:中哈福生物医药科技(上海)有限公司

Health care product for preventing and treating chemical liver injury

InactiveCN103519185AAuxiliary protectionFood preparationMedicineCurative effect
The invention discloses a health care product for preventing and treating a chemical liver injury. The health care product is prepared with schisandrin b and procyanidine as main raw materials, and the health care product has the exact curative effect on the chemical liver injury.
Owner:苏州天南星生物科技有限公司

Application of schisandrin B in drug preparation

ActiveCN107243004AAlleviate the effect of inflammatory responseEffective treatmentSenses disorderUrinary disorderOral medicationMechanism of action
The invention discloses application of schisandrin B in preparation of drugs for treatment of diabetic complications. Specifically, schisandrin B reaches the effect of treatment of diabetic complications through targeted inhibition of myeloid differentiation factor 88 (MyD88) to generate the action mechanism of lowering chronic inflammation. The schisandrin B is superior to oral administration (used for preparation of powder, tablets, pills, oral liquid and capsules). Schisandrin B can effectively relieve the occurrence and development of diabetic cardiomyopathy and diabetic nephropathy, and can become a main component in drugs for treatment of diabetic complications.
Owner:WENZHOU MEDICAL UNIV +1

Application of schisandrin B in preparation of drugs used for preventing colitis or colorectal carcinomas

The invention discloses application of schisandrin B in preparation of drugs used for preventing colitis or colorectal carcinomas. The usage amount of schisandrin B is 15 to 30 mg per kg of body weight. Schisandrin B can effectively prevent colitis and colorectal carcinomas related to colitis, so schisandrin B has clinical application prospect; schisandrin B has low toxicity and small side-effect, can reduce generation of inflammatory factors and has good druggability; thus, schisandrin B has good application prospects in clinical prevention and treatment.
Owner:ZHEJIANG DINGHUI PHARM

Schisandra chinensis dl-tetrahydropalmatine preparation

The invention discloses schisandra chinensis dl-tetrahydropalmatine preparation. Main raw materials of the preparation are schisandra chinensis dl-tetrahydropalmatine and granulesten. The preparation has exact curative effect on chemical liver injury.
Owner:苏州天南星生物科技有限公司

SchisandrinB solid dispersion as well as preparation method and preparation thereof

The invention provides a schisandrinB solid dispersion and a preparation method thereof as well as a medical preparation containing the solid dispersion. The schisandrinB solid dispersion is prepared from main raw materials including schisandrinB and povidone at the weight ratio of 1:(2-8) by a solvent method or a grinding method. The results of vitro dissolution, DSC and XRD examination and stability test of the obtained schisandrinB solid dispersion and the preparation thereof show that the prepared solid dispersion of the schisandrinB, disclosed by the invention, exists in an amorphism state or a molecular state, the vitro dissolution is greatly improved, the prepared preparation is stable, and the oral bioavailability of the schisandrinB is improved.
Owner:ZHEJIANG DINGHUI PHARM

Application of schisandrin B in preparation of drugs for preventing colitis or colon cancer

ActiveCN104825442BInhibit the activity of inflammatory cytokinesLow toxicityDigestive systemAntineoplastic agentsSide effectSchisandrin
The invention discloses an application of schisandrin B in the preparation of a drug for preventing colitis or colon cancer; the dosage of the schisandrin B is 15-30 mg / kg body weight; the schisandrin B can effectively prevent colitis and colitis-related colon cancer, has clinical application prospects; Schizandrin B has low toxicity and few side effects, which can reduce the production of inflammatory factors; Schizandrin B has good drug-making properties; therefore, Schizandrin B has good clinical application prospects for preventive treatment.
Owner:ZHEJIANG DINGHUI PHARM

A detection method and application of functional active ingredients of Spatholobus

The invention belongs to the technical field of the detection of components of traditional Chinese medicines, and discloses a detection method of effective components of radix seu caulis schisandrae propinquae and application. The detection method comprises steps of preparation of standard substance solutions of rutin, schizandrin A and schisandrin B respectively, preparation of a test sample solution, HPLC (High Performance Liquid Chromatography) detection and the like, wherein chromatographic conditions of the HPLC detection are as follows: a methanol-1 percent glacial acetic acid solution is used as mobile phase eluent; the gradient elution is carried out for 90min; volume fractions of methanol in the eluent corresponding to each time interval of the elution are respectively: 20 percentduring 0min to 20min, 40 percent during 20min to 40min, 60 percent during 40min to 60min, 80 percent during 60min to 80min and 100 percent during 80min to 90min; a flow speed is 1mL / min; a detectionwavelength is 257nm. The detection method uses the HPLC detection with the gradient elution, can be used for measuring three functional effective components in the radix seu caulis schisandrae propinquae at the same time, and can be used for more completely reflecting a pharmacodynamic effect of the radix seu caulis schisandrae propinquae.
Owner:HUAIHUA UNIV

Method for processing vinegar schisandra fruit

The invention relates to a method for processing vinegar schisandra fruit, which can effectively prepare medicinal material of the schisandra fruit into vinegar schisandra fruit medical herb in pieces. The invention has the concrete technical scheme comprises the following steps: taking the medicinal material of the schisandra fruit, removing the non-medicinal parts such as fruit stalks, stumps and the like, adding rice vinegar, decompressing and moistening until the rice vinegar is sucked up, braising at high pressure, drying and packaging so as to obtain the vinegar schisandra fruit. The method is simple and easy to operate, the color of the prepared vinegar schisandra fruit is uniform, and the indexes of the contents of water content, ash content and the like are all within a range specified by a dispensatory; compared with a normal-pressure vinegar braising product of the vinegar schisandra fruit, no obvious difference exists in the contents of general lignanoid, schisandrol A, schisandra fruit essence B and general organic acid; compared with the normal-pressure vinegar braising product, the contents of 5-hydroxymethyl furfural and general polysaccharide are higher; and compared with a traditional normal-pressure braising process, the processing method adopting high-pressure vinegar braising lowers energy consumption and saves time. Therefore, the invention can be popularized and used for large-scale production, provides concrete technical data for the processing of the vinegar schisandra fruit and provides ground for the execution of the standardized production operation rule of traditional Chinese medicine medical herb in pieces.
Owner:BEIJING HUAMIAO TRADITIONAL CHINESE MEDICINE ENG TECH DEV CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products